Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Insys Therapeutics Inc. INSYQ

Healthcare Biotechnology
Insys Therapeutics Inc is a specialty pharmaceutical company. It develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients' quality of life. The company have two marketed products; SUBSYS, a proprietary sublingual fentanyl spray; and SYNDROS, a proprietary orally administered liquid formulation of dronabinol. The company derives... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:INSYQ)

FDA Accepts New Drug Application for INSYS Therapeutics' Naloxone Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose

GlobeNewswire July 3, 2019

INSYS Therapeutics, Inc. Receives Court Approval of "First Day" Motions

GlobeNewswire June 12, 2019

INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy Liabilities

GlobeNewswire June 10, 2019

INSYS Therapeutics Reports First Quarter 2019 Results

GlobeNewswire May 10, 2019

INSYS Therapeutics Implements Leadership Changes

GlobeNewswire April 15, 2019

INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The College on Problems of Drug Dependence Annual Scientific Meeting

GlobeNewswire March 25, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs

Benzinga.com  March 23, 2019

36 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  March 19, 2019

Mid-Afternoon Market Update: Crude Oil Up 2.6%; Synchronoss Technologies Shares Drop After Q4 Results

Benzinga.com  March 13, 2019
View More News ››

Opinion & Analysis (OTCPK:INSYQ)

Playing the Big Cannabis Rebound

Regal Consulting February 5, 2019
View More Opinion ››

Bullboard Posts (OTCPK:INSYQ)

Bankruptcy

So from what I understand they are filing Bankruptcy so that they can't get sued anymore but can continue operations. Is this correct...
Gmoney$ - June 14, 2019

it's a buy today for me

looking for a DEAD CAT BOUNCE after the BIG selloff,so glta.
coolfooldumbguy - June 13, 2019

Clinical Study Collaboration

https://www.ftmig.com/cannabis-marijuana/insys-therapeutics-and-uc-san-diegos-center-for-medicinal-cannabis-research-expand...
Cannabeds - September 4, 2018

RE:Up 17% on news that INSY settles with $150 mil payment

Is the means the company can move forward  which is a good sign 
Hunter999 - August 23, 2018

What's going on here?

New to board. Notice HMMJ is still being a decent amount of this stock. What do you guys think is holding it down so much right now...
GrimesInvestor - May 4, 2018

RE:RE:Check out TBP

This board seems to be kind of quiet as of late. This news sounds positive for getting the price back on a positive track. 
Sped1111 - November 20, 2017
View more Bullboard ››

Theralase Technologies Inc.

Theralase Technologies Inc.

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research ...
View More »